Gerd Stehle

This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Cancer Treatment. Top assignees: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Boehringer Ingelheim International Gmbh, Other. Active years: 1999-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerd Stehle. Retrieved from https://idiyas.com/inventor/gerd-stehle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 4

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 84(Granted Patents)

Location History:

Wieblingen, DE (2001)
Mannheim, DE (1999 - 2002)
Heidelberg, DE (2000 - 2004)
Ehingen, DE (2004 - 2017)

Company Filing History:

9 out of 168

Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts

patents

3 out of 1,564

Boehringer Ingelheim International Gmbh

patents

2 out of 834,601

Other

patents

Years Active: 1999-2017

Loading Chart...

Areas of Expertise:

Quinazoline Derivatives

Cancer Treatment

Conjugate Technologies

Active Substance

Inflammatory Diseases

Fluorescent Conjugate

Radiation Detection

Polypeptide

Polyether

Medicament Dosing

Folic Acid Antagonist

Chlorins

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9539258 - Quinazoline derivatives for the treatment of cancer diseases (2017-01-10),

2. 9089571 - Quinazoline derivatives for the treatment of cancer diseases (2015-07-28),

3. 8404697 - Quinazoline derivatives for the treatment of cancer diseases (2013-03-26),

4. 6812209 - Conjugate consisting of an active substance and a non-exogenous native protein (2004-11-02),

5. 6720304 - Conjugate comprising a folic acid antagonist and a carrier (2004-04-13),

6. 6706713 - Conjugate for treating inflammatory infectious and/or skin diseases (2004-03-16),

7. 6410695 - Individual medicament dosing conjugate (2002-06-25),

8. 6395254 - Conjugate comprising an active agent, a polypeptide and a polyether (2002-05-28),

9. 6310352 - Radiation detection device (2001-10-30),

10. 6306367 - Fluorescent conjugate for differentiating between diseased and healthy tissues (2001-10-23),

11. 6177561 - Preparation of acid amides and metallization of compounds (2001-01-23),

12. 6150327 - Conjugate of an active agent, a polyether and possibly a native protein (2000-11-21),

13. 6147207 - Method for producing chlorins and bacteriochlorins containing polyether (2000-11-14),

14. 5906977 - Conjugate for treating inflammatory diseases (1999-05-25),

Title: The Innovative Journey of Gerd Stehle

Introduction: Gerd Stehle, a visionary inventor hailing from Ehingen, Germany, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Gerd Stehle holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Gerd Stehle has worked with leading research institutions and technology companies to bring his innovative ideas to life. His passion for pushing the boundaries of technology has led to the development of cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Gerd Stehle has collaborated with top engineers, scientists, and designers to transform his concepts into tangible products. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Gerd Stehle's relentless pursuit of innovation and his dedication to creating solutions that address global challenges have established him as a prominent figure in the world of technology. His inventive spirit continues to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.